The study, funded by Diabetes UK, is a multi-site study being run in 8 PCTs around England. Patients newly diagnosed with type 2 diabetes were referred to the trial. Participants attended a DESMOND course during which they learnt about self-monitoring using either blood glucose testing or urine testing.
The Self Monitoring Study is being conducted due to the lack of robust evidence on the benefits of self-monitoring. Outcomes of patients self-monitoring using either blood glucose or urinalysis is being compared.
The Standard DEMSOND course has been developed to include an enhanced module on self-monitoring and 24 educators have been trained to deliver this.
Recruitment to the trial has now stopped and follow-up data are being collected. Although the total number recruited is below target, the research team are working hard to maximise the return of follow-up data.
The follow-up period is 18 months.
A number of participants will also take part in one-to -one interviews during which they will discuss their experiences of and preferences for monitoring type.